(EHTH) eHealth - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US28238P1093

EHTH: Health Insurance, Medicare, Dental, Vision, Disability

eHealth, Inc. (NASDAQ:EHTH) is a leading health insurance marketplace specializing in consumer engagement, education, and enrollment solutions. The company operates through two primary segments: Medicare and Employer & Individual. The Medicare segment focuses on Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement, and Medicare Part D prescription drug plans. It also offers ancillary products like dental and vision insurance, along with advertising and marketing services tailored for Medicare-eligible customers. The Employer & Individual segment provides health insurance solutions for individuals, families, and small businesses, including ancillary products such as dental, vision, and disability insurance. Additionally, eHealth delivers ecommerce platforms and consumer engagement tools, offering detailed insurance information to help customers research, compare, and purchase health insurance plans. The company markets its services through multiple websites, including eHealth.com, eHealthMedicare.com, and Medicare.com. It also generates revenue through online sponsorship, advertising, lead referral, technology licensing, and post-enrollment services for Medicare members. Founded in 1997, eHealth is headquartered in Austin, Texas.

Technically, EHTH is currently trading below its 20-day and 50-day moving averages, with a last price of $8.81. The stocks average 20-day volume is 330,217 shares, and its ATR is 0.64, indicating moderate volatility. From a fundamental perspective, eHealth has a market cap of $263.44 million, with a forward P/E of 13.44 and a P/B ratio of 0.56, suggesting undervaluation relative to book value. However, the companys RoE is -7.77, reflecting profitability challenges.

Based on and , the 3-month outlook for EHTH is as follows: - The stock is likely to remain under pressure in the near term, given its position below key moving averages (SMA 20: $9.90, SMA 50: $9.50). - Support levels may be tested near $8.00, with potential resistance at $10.50. - The ATR of 0.64 suggests moderate price swings, with average volatility expected to continue. - Fundamentally, while the low P/B ratio may attract value investors, the negative RoE and lack of earnings growth could limit upside momentum. - Overall, EHTH is expected to trade in a range-bound pattern, with potential for slight downside given its current technical setup and mixed fundamental trends.

Additional Sources for EHTH Stock

EHTH Stock Overview

Market Cap in USD 243m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Insurance Brokers
IPO / Inception 2006-10-13

EHTH Stock Ratings

Growth 5y -62.7%
Fundamental -1.95%
Dividend 0.0%
Rel. Strength Industry 6.35
Analysts 3.4/5
Fair Price Momentum 5.41 USD
Fair Price DCF -

EHTH Dividends

No Dividends Paid

EHTH Growth Ratios

Growth Correlation 3m 13.6%
Growth Correlation 12m 45.9%
Growth Correlation 5y -83.8%
CAGR 5y -39.78%
CAGR/Max DD 5y -0.41
Sharpe Ratio 12m -0.86
Alpha 19.09
Beta 0.78
Volatility 76.11%
Current Volume 148k
Average Volume 20d 253.8k
What is the price of EHTH stocks?
As of March 16, 2025, the stock is trading at USD 7.83 with a total of 147,984 shares traded.
Over the past week, the price has changed by -3.57%, over one month by -29.71%, over three months by +43.41% and over the past year by +28.36%.
Is eHealth a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, eHealth is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.95 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EHTH as of March 2025 is 5.41. This means that EHTH is currently overvalued and has a potential downside of -30.91%.
Is EHTH a buy, sell or hold?
eHealth has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold EHTH.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for EHTH stock price target?
According to ValueRays Forecast Model, EHTH eHealth will be worth about 5.9 in March 2026. The stock is currently trading at 7.83. This means that the stock has a potential downside of -24.39%.
Issuer Forecast Upside
Wallstreet Target Price 10.6 35.8%
Analysts Target Price 8.6 10.2%
ValueRay Target Price 5.9 -24.4%